|
TCMBANKGE001111 |
KIT |
C-Kit; CD117; MASTC; PBT; SCFR |
KIT proto-oncogene, receptor tyrosine kinase |
|
TCMBANKGE014824 |
TNFSF15 |
TL1; TL1A; TNLG1B; VEGI; VEGI192A |
TNF superfamily member 15 |
|
TCMBANKGE001522 |
ALAS2 |
ALAS-E; ALASE; ANH1; ASB; SIDBA1; XLDPP; XLEPP; XLSA |
5'-aminolevulinate synthase 2 |
|
TCMBANKGE000153 |
USP7 |
HAUSP; TEF1 |
ubiquitin specific peptidase 7 |
|
TCMBANKGE013904 |
COX7B |
APLCC; LSDMCA2 |
cytochrome c oxidase subunit 7B |
|
TCMBANKGE009869 |
GNAQ |
CMC1; G-ALPHA-q; GAQ; SWS |
G protein subunit alpha q |
|
TCMBANKGE000173 |
BRAF |
B-RAF1; B-raf; BRAF1; NS7; RAFB1 |
B-Raf proto-oncogene, serine/threonine kinase |
|
TCMBANKGE006657 |
MC2R |
ACTHR |
melanocortin 2 receptor |
|
TCMBANKGE008380 |
IRF5 |
SLEB10 |
interferon regulatory factor 5 |
|
TCMBANKGE001998 |
NR0B1 |
AHC; AHCH; AHX; DAX-1; DAX1; DSS; GTD; HHG; NROB1; SRXY2 |
nuclear receptor subfamily 0 group B member 1 |
|
TCMBANKGE002962 |
NDUFB11 |
CI-ESSS; ESSS; MC1DN30; NP17.3; Np15; P17.3 |
NADH:ubiquinone oxidoreductase subunit B11 |
|
TCMBANKGE014979 |
NOD2 |
ACUG; BLAU; BLAUS; CARD15; CD; CLR16.3; IBD1; NLRC2; NOD2B; PSORAS1; YAOS |
nucleotide binding oligomerization domain containing 2 |
|
TCMBANKGE009239 |
SRD5A3 |
CDG1P; CDG1Q; KRIZI; SRD5A2L; SRD5A2L1 |
steroid 5 alpha-reductase 3 |
|
TCMBANKGE012356 |
TGM5 |
PSS2; TGASE5; TGASEX; TGM6; TGMX; TGX |
transglutaminase 5 |
|
TCMBANKGE007825 |
RPL27A |
L27A |
ribosomal protein L27a |
|
TCMBANKGE004056 |
PANK2 |
C20orf48; HARP; HSS; NBIA1; PKAN |
pantothenate kinase 2 |
|
TCMBANKGE005145 |
SDHC |
CYB560; CYBL; PGL3; QPS1; SDH3 |
succinate dehydrogenase complex subunit C |
|
TCMBANKGE002967 |
AAAS |
AAA; AAASb; ADRACALA; ADRACALIN; ALADIN; GL003 |
aladin WD repeat nucleoporin |
|
TCMBANKGE007327 |
UROS |
UROIIIS |
uroporphyrinogen III synthase |
|
TCMBANKGE000243 |
LMNA |
CDCD1; CDDC; CMD1A; CMT2B1; EMD2; FPL; FPLD; FPLD2; HGPS; IDC; LDP1; LFP; LGMD1B; LMN1; LMNC; LMNL1; MADA; PRO1 |
lamin A/C |
|
TCMBANKGE000271 |
APOE |
AD2; APO-E; ApoE4; LDLCQ5; LPG |
apolipoprotein E |
|
TCMBANKGE000127 |
MFN2 |
CMT2A; CMT2A2; CMT2A2A; CMT2A2B; CPRP1; HMSN6A; HSG; MARF |
mitofusin 2 |
|
TCMBANKGE013134 |
NHP2 |
DKCB2; NHP2P; NOLA2 |
NHP2 ribonucleoprotein |
|
TCMBANKGE014996 |
POU2AF1 |
BOB1; OBF-1; OBF1; OCAB |
POU class 2 homeobox associating factor 1 |
|
TCMBANKGE007797 |
KITLG |
DCUA; DFNA69; FPH2; FPHH; KL-1; Kitl; MGF; SCF; SF; SHEP7; SLF |
KIT ligand |
|
TCMBANKGE003615 |
TXNRD2 |
GCCD5; SELZ; TR; TR-BETA; TR3; TRXR2 |
thioredoxin reductase 2 |
|
TCMBANKGE005984 |
TFR2 |
HFE3; TFRC2 |
transferrin receptor 2 |
|
TCMBANKGE001106 |
MTOR |
FRAP; FRAP1; FRAP2; RAFT1; RAPT1; SKS |
mechanistic target of rapamycin kinase |
|
TCMBANKGE000916 |
SMO |
CRJS; FZD11; Gx; SMOH |
smoothened, frizzled class receptor |
|
TCMBANKGE002136 |
GBA |
GBA1; GCB; GLUC |
glucosylceramidase beta |
|
TCMBANKGE007509 |
KRT5 |
CK5; DDD; DDD1; EBS2; K5; KRT5A |
keratin 5 |
|
TCMBANKGE000889 |
HFE |
HFE1; HH; HLA-H; MVCD7; TFQTL2 |
homeostatic iron regulator |
|
TCMBANKGE010212 |
PSMB8 |
ALDD; D6S216; D6S216E; JMP; LMP7; NKJO; PRAAS1; PSMB5i; RING10 |
proteasome 20S subunit beta 8 |
|
TCMBANKGE011987 |
TP63 |
AIS; B(p51A); B(p51B); EEC3; KET; LMS; NBP; OFC8; RHS; SHFM4; TP53CP; TP53L; TP73L; p40; p51; p53CP; p63; p73H; p73L |
tumor protein p63 |
|
TCMBANKGE011193 |
RPS27 |
DBA17; MPS-1; MPS1; S27 |
ribosomal protein S27 |
|
TCMBANKGE004127 |
CSTA |
AREI; PSS4; STF1; STFA |
cystatin A |
|
TCMBANKGE014404 |
HMGA2 |
BABL; HMGI-C; HMGIC; LIPO; STQTL9 |
high mobility group AT-hook 2 |
|
TCMBANKGE000407 |
DYRK1A |
DYRK; DYRK1; HP86; MNB; MNBH; MRD7 |
dual specificity tyrosine phosphorylation regulated kinase 1A |
|
TCMBANKGE008722 |
APC |
BTPS2; DESMD; DP2; DP2.5; DP3; GS; PPP1R46 |
APC regulator of WNT signaling pathway |
|
TCMBANKGE014262 |
CYP11B1 |
CPN1; CYP11B; FHI; P450C11 |
cytochrome P450 family 11 subfamily B member 1 |
|
TCMBANKGE009742 |
HLA-DRB1 |
DRB1; HLA-DR1B; HLA-DRB; SS1 |
major histocompatibility complex, class II, DR beta 1 |
|
TCMBANKGE009234 |
COL7A1 |
EBD1; EBDCT; EBR1; NDNC8 |
collagen type VII alpha 1 chain |
|
TCMBANKGE011372 |
ANTXR2 |
CMG-2; CMG2; HFS; ISH; JHF |
ANTXR cell adhesion molecule 2 |
|
TCMBANKGE010737 |
MMEL1 |
MMEL2; NEP2; NEPII; NL1; NL2; SEP |
membrane metalloendopeptidase like 1 |
|
TCMBANKGE001056 |
KRAS |
C-K-RAS; C-K-RAS; CFC2; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; K-Ras; K-Ras 2; KI-RAS; KRAS1; KRAS2; NS; NS3; OES; RALD; RASK2; c-Ki-ras; c-Ki-ras2 |
KRAS proto-oncogene, GTPase |
|
TCMBANKGE000198 |
KCNMA1 |
BKTM; CADEDS; IEG16; KCa1.1; LIWAS; MaxiK; PNKD3; SAKCA; SLO; SLO-ALPHA; SLO1; bA205K10.1; hSlo; mSLO1 |
potassium calcium-activated channel subfamily M alpha 1 |
|
TCMBANKGE000504 |
IL12A |
CLMF; IL-12A; NFSK; NKSF1; P35 |
interleukin 12A |
|
TCMBANKGE014489 |
CYP11A1 |
CYP11A; CYPXIA1; P450SCC |
cytochrome P450 family 11 subfamily A member 1 |
|
TCMBANKGE000637 |
SDHB |
CWS2; IP; PGL4; SDH; SDH1; SDH2; SDHIP |
succinate dehydrogenase complex iron sulfur subunit B |
|
TCMBANKGE007024 |
SLC29A3 |
ENT3; HCLAP; HJCD; PHID |
solute carrier family 29 member 3 |
|
TCMBANKGE001108 |
BMP2 |
BDA2; BMP2A; SSFSC |
bone morphogenetic protein 2 |
|
TCMBANKGE000244 |
ZMPSTE24 |
FACE-1; FACE1; HGPS; PRO1; STE24; Ste24p |
zinc metallopeptidase STE24 |
|
TCMBANKGE008830 |
JAK3 |
JAK-3; JAK3_HUMAN; JAKL; L-JAK; LJAK |
Janus kinase 3 |
|
TCMBANKGE007317 |
FANCC |
FA3; FAC; FACC |
FA complementation group C |
|
TCMBANKGE005792 |
NOP10 |
DKCB1; NOLA3; NOP10P |
NOP10 ribonucleoprotein |
|
TCMBANKGE001080 |
AHR |
RP85; bHLHe76 |
aryl hydrocarbon receptor |
|
TCMBANKGE011884 |
DKC1 |
CBF5; DKC; DKCX; NAP57; NOLA4; XAP101 |
dyskerin pseudouridine synthase 1 |
|
TCMBANKGE000639 |
HRAS |
C-BAS/HAS; C-H-RAS; C-HA-RAS1; CTLO; H-RASIDX; HAMSV; HRAS1; RASH1; p21ras |
HRas proto-oncogene, GTPase |
|
TCMBANKGE014144 |
LEMD3 |
MAN1 |
LEM domain containing 3 |
|
TCMBANKGE002626 |
SPIB |
SPI-B |
Spi-B transcription factor |
|
TCMBANKGE011163 |
MYO5A |
GS1; MYH12; MYO5; MYR12 |
myosin VA |
滇IICP备16009434号-1 |
Dai SX Lab